Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4696 to 4710 of 8221 results

  1. Does early review of service provision and referral to additional specialist palliative care services improve outcomes for adults with progressive non-cancer disease thought to be approaching the end of their life?

    Recommendation ID NG142/1 Question Does early review of service provision and referral to additional specialist palliative care services

  2. E-cigarettes and established future smoking: Is e‑cigarette use in children, young people and young adults who do not smoke associated with future established smoking?

    Recommendation ID NG209/09 Question E-cigarettes and established future smoking: Is e‑cigarette use in children, young people and young

  3. What is the role of educational models and psycho-behavioural interventions in prevention of diabetic foot complications?

    Recommendation ID NG19/3 Question What is the role of educational models and psycho-behavioural interventions in prevention of diabetic

  4. When and with what criteria should people with diabetes be referred to the foot protection service or the multidisciplinary foot care service?

    Recommendation ID NG19/2 Question When and with what criteria should people with diabetes be referred to the foot protection service or

  5. Education and psycho-behavioural interventions for prevention:- What is the role of educational models and psycho-behavioural interventions in prevention of diabetic foot complications?

    Recommendation ID NG19/3 Question Education and psycho-behavioural interventions for prevention:- What is the role of educational models

  6. What  components   and  characteristics   of digital and mobile health behaviour change interventions are most effective, separately and in combination, to achieve behaviour change?

    Recommendation ID NG183/2 Question What components and characteristics of digital and mobile health behaviour change interventions

  7. What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment in babies, children and young people with chemotherapy-induced nausea or vomiting which persists with optimised conventional antiemetics?

    Recommendation ID NG144/7 Question What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment

  8. What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment for adults with chemotherapy-induced nausea and vomiting which persists with optimised conventional antiemetics?

    Recommendation ID NG144/6 Question What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment

  9. Chronic conditions:- What is the prevalence of disease in the UK prison population?

    Recommendation ID NG57/2 Question Chronic conditions:- What is the prevalence of disease in the UK prison population? Any explanatory